Helix, founded on July 15, 2015, by Scott Burke, Justin Kao, and James Lu, is a leading population genomics company headquartered in San Mateo, California. It operates at the intersection of clinical care, research, and genomics, providing an end-to-end platform for health systems, life sciences companies, and payers to advance genomic research and integrate genomic data into clinical care. Helix's primary product is genomic testing, and it serves the United States market.
Helix has made significant strides in the genomics industry, leveraging its platform to facilitate the integration of genomic data into clinical settings. Under the leadership of CEO Marc Stapley, the company has grown to employ between 150-200 people. Helix's impact is evident in its collaborations with various health systems and life sciences companies, driving forward the use of genomics in personalized medicine and research.
